Severe Acute Respiratory Syndrome (SARS) Therapeutics Report

By www.reliablebusinessarena.com

Report Details

Report Name

Global And United States Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Report & Forecast 2024-2031 Story

Pages

88

Price

$ 4350

Features

Severe Acute Respiratory Syndrome (SARS) Therapeutics Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              CEL-SCI Corporation
GeneCure LLC
Humabs BioMed SA
Inovio Pharmaceuticals, Inc.
Nanotherapeutics, Inc.
Novavax, Inc.
Phelix Therapeutics, LLC
Protein Sciences Corporation